The Expense Line Nobody Challenged
The Expense Line Nobody Challenged. A measured VisionWise Capital review of the evidence, risks, investor questions, and decision process.
How to Compare a Multifamily Property’s Income and Operating Costs
How to Compare a Multifamily Property’s Income and Operating Costs. A measured VisionWise Capital review of the evidence, risks, investor questions, and de
The Renewal Notice in the Underwriting File
The Renewal Notice in the Underwriting File. A measured VisionWise Capital review of the evidence, risks, investor questions, and decision process.
Southern California Multifamily Investing and Insurance Costs: What Investors Should Ask
Southern California Multifamily Investing and Insurance Costs: What Investors Should Ask. A measured VisionWise Capital review of the evidence, risks, inve
The Tax Question That Stopped a Fast Decision
The Tax Question That Stopped a Fast Decision. A measured VisionWise Capital review of the evidence, risks, investor questions, and decision process.
Roth vs. Traditional Self-Directed IRA for Private Real Estate
Roth vs. Traditional Self-Directed IRA for Private Real Estate. A measured VisionWise Capital review of the evidence, risks, investor questions, and decisi
The Question Missing From the Offering Summary
The Question Missing From the Offering Summary. A measured VisionWise Capital review of the evidence, risks, investor questions, and decision process.
Private Real Estate Offering Documents: Nine Questions Before You Sign
Private Real Estate Offering Documents: Nine Questions Before You Sign. A measured VisionWise Capital review of the evidence, risks, investor questions, an
Three Vacant Units and a Wrong Assumption
Three Vacant Units and a Wrong Assumption. A measured VisionWise Capital review of the evidence, risks, investor questions, and decision process.
Orange County Multifamily Investment: How to Read Vacancy, Rents, and Repairs Together
Orange County Multifamily Investment: How to Read Vacancy, Rents, and Repairs Together. A measured VisionWise Capital review of the evidence, risks, invest